West Nadja

SEC Form 4 insider trading activity

West Nadja has filed 9 SEC Form 4 filings (10 transaction rows) across 3 companies, including THC, TEM, NUE, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, West Nadja is listed as Director at TENET HEALTHCARE CORP. Inside the rolling window, West Nadja reported no open-market purchases and 5 open-market sales totaling $1.6M in THC and TEM. The largest disclosed transaction in the window is a sale of 3,000 THC shares on May 27, 2026, worth $532K.

Companies traded

Other insiders at THC

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.6M

reported sales (SEC code S)

Companies

3

in the rolling window

Source
THCSale$298KSep 3SEC ↗
TEMSale$207KSep 1SEC ↗
TEMSale$162KAug 18SEC ↗
THCSale$532KMay 29SEC ↗
THCSale$430KDec 17SEC ↗

Frequently asked questions

How many SEC Form 4 filings has West Nadja made?

West Nadja has filed 9 SEC Form 4 filings (10 transaction rows) across 3 companies, including THC, TEM, NUE since 2025.

Which companies does West Nadja trade?

West Nadja has filed SEC Form 4 disclosures for 3 companies, including THC, TEM, NUE.

When was West Nadja's most recent SEC Form 4 filing?

West Nadja's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is West Nadja's total buy and sell value in the current window?

Inside the rolling retention window, West Nadja bought $0 and sold $1.6M based on SEC Form 4 filings.

What was West Nadja's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 3,000 THC shares on 2026-05-27, worth $532K, per SEC Form 4 filings.